Results 151 to 160 of about 198,186 (294)

Echocardiography in Athletes: the Ever-Evolving Assessment of Physiology Versus Pathology. [PDF]

Curr Cardiol Rep
Fritzlen JT, Martinez MW.
europepmc   +1 more source

Left Ventricular Hypertrophy [PDF]

, 2020
openaire   +1 more source

Fetal Ductal Constriction, Pulmonary Hypertension and Atrial Septum Mobility

Journal of Ultrasound in Medicine, EarlyView.
Objectives Fetuses with ductal constriction (FDC), pulmonary hypertension and right ventricular overload after maternal exposure to PGE2 inhibitors—nonsteroidal anti‐inflammatory drugs (NSAIDs) or polyphenols (PF)—have increased septum primum excursion index (SPEI), the ratio between maximal septum primum displacement and left atrial diameter.
Paulo Zielinsky, Polyanna Henriques, Pedro Van Der Sand, Maria Antonia Saldanha, Gabriela Macelaro, Joana Nicoloso   +5 more
wiley   +1 more source

Apical Sparing of Longitudinal Strain and Myocardial Fibrosis in Hypertensive Patients and Spontaneously Hypertensive Rats: Based on Speckle Tracking and Histological Analysis. [PDF]

Clin Cardiol
Huang C, Wu Y, Lin M, Chen Y, Lin S, Fu L, Huang H.   +6 more
europepmc   +1 more source

Risk factors associated with sudden death vs. congestive heart failure or arterial thromboembolism in cats with hypertrophic cardiomyopathy [PDF]

, 2016
Borgeat, K A, Brodbelt, D C, Connolly, D J, Fuentes, V L, Payne, J R   +4 more
core   +1 more source

MiR‐145‐5p Attenuates Doxorubicin‐Induced Heart Injury Through Targeting Cardiomyocyte Pyroptosis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Doxorubicin (DOX), a potent anthracycline chemotherapeutic, exhibits dose‐dependent cardiotoxicity that limits its clinical utility. Although miR‐145‐5p demonstrates cardioprotective properties in cardiovascular diseases, its role in DOX‐induced cardiomyopathy remains undefined.
Xing‐Tao Chen, Yong‐Hong Yu, Yan‐Hua Du, Lin Xu, Xiang‐Ping Meng   +4 more
wiley   +1 more source

Left ventricular hypertrophy and myocardial fibrosis in heart failure with preserved ejection fraction: mechanisms and treatment. [PDF]

Eur Heart J
Peikert A, Fontana M, Solomon SD, Thum T.   +3 more
europepmc   +1 more source

Left Ventricular Hypertrophy [PDF]

, 2005
openaire   +1 more source

Left Ventricular Hypertrophy

Medicine & Science in Sports & Exercise, 2018
Gabriele Mascherini, Cristian Petri, Giorgio Galanti   +2 more
openaire   +2 more sources

Sacubitril/Valsartan Ameliorates Inflammation and Oxidative Stress in Hypertensive Heart Disease by Upregulating CAMKK2 Protein and Modulating the AMPK/AKT/GSK‐3β Axis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Sacubitril/valsartan (Sac/Val) has emerged as an effective compound with myocardium‐protective functions in experimental and clinical trials for heart failure. This study investigated the function of Sac/Val in hypertensive heart disease (HHD) and explored the underlying mechanism.
Yan‐Jun Yang, Jiu‐Sheng Li
wiley   +1 more source